STRATEGIES FOR ANTIVIRAL THERAPY IN AIDS

[31] SURAMIN PROTECTION OF T-CELLS INVITRO AGAINST INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III [J]. SCIENCE, 1984, 226 (4671) : 172 - 174

[32] INHIBITION OF THE INVITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPHIC-T VIRUS "TYPE-III/LYMPHADENOPATHY-ASSOCIATED VIRUS (HTLV-III/LAV) BY 2',3'-DIDEOXYNUCLEOSIDES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) : 1911 - 1915

[33] 3'-AZIDO-3'-DEOXYTHYMIDINE (BW A509U) - AN ANTIVIRAL AGENT THAT INHIBITS THE INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPIC-T VIRUS TYPE-III LYMPHADENOPATHY-ASSOCIATED VIRUS INVITRO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (20) : 7096 - 7100

[34] MITSUYA H, IN PRESS P NATN ACAD

[35] DEMONSTRATION OF VIRUS-SPECIFIC TRANSCRIPTIONAL ACTIVATOR(S) IN CELLS INFECTED WITH HTLV-III BY AN INVITRO CELL-FREE SYSTEM [J]. CELL, 1986, 47 (01) : 29 - 35

[36] INDUCTION OF ENDOGENOUS VIRUS AND OF THYMIDINE KINASE BY BROMODEOXYURIDINE IN CELL-CULTURES TRANSFORMED BY FRIEND VIRUS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (12) : 4980 - 4985

[37] OCTAPEPTIDES DEDUCED FROM THE NEUROPEPTIDE RECEPTOR-LIKE PATTERN OF ANTIGEN-T4 IN BRAIN POTENTLY INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS RECEPTOR-BINDING AND T-CELL INFECTIVITY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (23) : 9254 - 9258

[38] DETECTION, ISOLATION, AND CONTINUOUS PRODUCTION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND PRE-AIDS [J]. SCIENCE, 1984, 224 (4648) : 497 - 500

[39] COMPLETE NUCLEOTIDE-SEQUENCE OF THE AIDS VIRUS, HTLV-III [J]. NATURE, 1985, 313 (6000) : 277 - 284

[40] INTRA-BLOOD BRAIN-BARRIER SYNTHESIS OF HTLV-III-SPECIFIC IGG IN PATIENTS WITH NEUROLOGIC SYMPTOMS ASSOCIATED WITH AIDS OR AIDS-RELATED COMPLEX [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (24) : 1498 - 1504

[31] SURAMIN PROTECTION OF T-CELLS INVITRO AGAINST INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III [J]. SCIENCE, 1984, 226 (4671) : 172 - 174

[32] INHIBITION OF THE INVITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPHIC-T VIRUS "TYPE-III/LYMPHADENOPATHY-ASSOCIATED VIRUS (HTLV-III/LAV) BY 2',3'-DIDEOXYNUCLEOSIDES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) : 1911 - 1915

[33] 3'-AZIDO-3'-DEOXYTHYMIDINE (BW A509U) - AN ANTIVIRAL AGENT THAT INHIBITS THE INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPIC-T VIRUS TYPE-III LYMPHADENOPATHY-ASSOCIATED VIRUS INVITRO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (20) : 7096 - 7100

[34] MITSUYA H, IN PRESS P NATN ACAD

[35] DEMONSTRATION OF VIRUS-SPECIFIC TRANSCRIPTIONAL ACTIVATOR(S) IN CELLS INFECTED WITH HTLV-III BY AN INVITRO CELL-FREE SYSTEM [J]. CELL, 1986, 47 (01) : 29 - 35

[36] INDUCTION OF ENDOGENOUS VIRUS AND OF THYMIDINE KINASE BY BROMODEOXYURIDINE IN CELL-CULTURES TRANSFORMED BY FRIEND VIRUS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (12) : 4980 - 4985

[37] OCTAPEPTIDES DEDUCED FROM THE NEUROPEPTIDE RECEPTOR-LIKE PATTERN OF ANTIGEN-T4 IN BRAIN POTENTLY INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS RECEPTOR-BINDING AND T-CELL INFECTIVITY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (23) : 9254 - 9258

[38] DETECTION, ISOLATION, AND CONTINUOUS PRODUCTION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND PRE-AIDS [J]. SCIENCE, 1984, 224 (4648) : 497 - 500

[39] COMPLETE NUCLEOTIDE-SEQUENCE OF THE AIDS VIRUS, HTLV-III [J]. NATURE, 1985, 313 (6000) : 277 - 284

[40] INTRA-BLOOD BRAIN-BARRIER SYNTHESIS OF HTLV-III-SPECIFIC IGG IN PATIENTS WITH NEUROLOGIC SYMPTOMS ASSOCIATED WITH AIDS OR AIDS-RELATED COMPLEX [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (24) : 1498 - 1504